| Literature DB >> 24606951 |
Amy Duncan1, Deborah Turnbull, Carlene Wilson, Joanne M Osborne, Stephen R Cole, Ingrid Flight, Graeme P Young.
Abstract
BACKGROUND: Social cognitive variables are often examined for their association with initial participation in colorectal cancer screening. Few studies have examined the association of these variables with adherence to multiple screening offers i.e., rescreening. This study aimed to describe patterns of participatory behaviour after three rounds of screening using faecal immunochemical tests (FIT) and to determine social cognitive, demographic and background variables predictive of variations in adherence.Entities:
Mesh:
Year: 2014 PMID: 24606951 PMCID: PMC4234274 DOI: 10.1186/1471-2458-14-238
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Social cognitive items included in the behavioural questionnaire
| “My good health is largely a matter of good fortune” | 4 | Wallston et al.
[ | |
| “If I take the right actions I can stay healthy” | 2 | Wallston et al.
[ | |
| “If you don’t have your health you don’t have anything” | 4 | Lau & Hartman
[ | |
| “Participation in home stool test screening leads to early detection if something is wrong.” | 4 | Boer & Seydel
[ | |
| “I am confident that I will be able to screen regularly for bowel cancer with a home stool test even if I find the test to be embarrassing” | 6 | - | |
| “Home stool tests are inconvenient” | 7 | - | |
| “Screening can pick up bowel cancer early when it can be easily treated” | 4 | - | |
| “The health consequences of developing bowel cancer are severe” | 2 | Gregory et al.
[ | |
| “Compared to other people my age my chance of getting bowel cancer is high” | 2 | Gregory et al.
[ | |
| “I can count on my friends when things go wrong” | 6 | Gregory et al.
[ | |
| “My doctor thinks I should have bowel cancer screening” | 4 | Tiro et al.
[ |
FIT screening patterns and behaviours defined after three annual screening rounds
| Y | Y | Y | Consistent re-participation |
| Y | Y | N | Drop out |
| Y | N | N | |
| N | Y | N | |
| Y | N | Y | Intermittent re-participation |
| N | Y | Y | Delayed entry |
| N | N | Y | |
| N | N | N | Consistent refusal |
Figure 1Process of determining eligibility for analyses.
Proportion of study participants in each adherence category upon study completion (i.e., at year 3)
| Consistent re-participation | 860 (55.8%) |
| Drop out | 134 (8.7%) |
| Intermittent re-participation | 68 (4.4%) |
| Delayed entry | 166 (10.8%) |
| Consistent refusal | 312 (20.3%) |
| Total | 1540 (100%) |
Significant social cognitive differences between consistent re-participation and each non-adherent category
| 17.96 (4.33)** | 16.51 (3.65) | 16.57 (4.34) | 18.04(4.80)** | 12.46 (4,709.51) | <.001 | ||
| 15.74 (1.99) | 15.96 (1.75) | 15.90 (1.93) | 15.07(2.24)** | 16.49 (4,1535) | <.001 | ||
| 22.36 (4.29)* | 23.63 (4.22) | 23.35 (4.61) | 21.57(5.01)** | 14.24 (4,678.72) | <.001 | ||
| 11.26 (1.13) | 10.79 (1.88) | 10.96 (1.61) | 10.46(1.73)** | 36.94 (4)a | <.001 | ||
| 22.91 (3.61) | 22.88 (3.26) | 22.47 (3.52) | 21.80(4.38)** | 5.80 (4,725.81) | <.001 | ||
| 13.52 (2.61) | 13.13 (2.65) | 13.38 (2.43) | 12.75(2.78)** | 8.79 (4,1535) | <.001 |
Note. F = F ratio; df = degrees of freedom, SD = standard deviation, p = probability. Data were measured on increasing, continuous scales.
adata were not normally distributed therefore the Kruskal-Wallis test was reported.
*p < .05. **p < .01.
Demographic and background differences between consistent re-participation and categories of non-adherence
| | |||||||
| Agea | 58.86 (6.55)** | 57.69 (6.20)** | 57.86 (5.57)** | 58.57 (6.62)** | 19.92 (4,599.32) | <.001 | |
| 4.04 (1.13) | 3.47 (1.31)** | 3.95 (1.23) | 3.85 (1.29) | 3.29 (4,546.14) | .011 | ||
| Private health insurance, | 33 (25.0)** | 17 (25.0) | 31 (18.7) | 75 (24.1) | 26.80 (12) | .008 | |
| | 21 (15.9) | 6 (8.8) | 9 (5.4) | 21 (6.8) | | | |
| | 5 (3.8) | 4 (5.9) | 9 (5.4) | 14 (4.5) | | | |
| | 73 (55.3) | 41 (60.3) | 117 (70.5) | 201 (64.6) | | | |
| Gender ( | 58 (43.3) | 24 (35.3) | 100 (60.2)** | 159 (51.0) | 23.48 (4) | <.001 | |
| Married ( | 93 (70.5) ** | 54 (79.4) | 131 (79.4) | 222 (71.2)** | 16.46 (4) | .002 | |
| Workforce | 78 (60.0)** | 43 (64.2)** | 109 (66.5)** | 189 (61.4)** | 45.88 (4) | <.001 | |
| Disadvantage, 1 | 28 (20.9) | 16 (23.9) | 34 (19.4) | 81 (26.0)** | 36.73 (16) | .002 | |
| | 35 (26.1) | 11 (16.4) | 26 (15.8) | 56 (18.0) | | | |
| | 20 (14.9) | 16 (23.9) | 20 (12.1) | 39 (12.5) | | | |
| | 24 (17.9) | 4 (6.0) | 31 (18.8) | 34 (10.9) | | | |
| | 27 (20.1) | 20 (29.9) | 54 (32.7) | 101 (32.5) | | | |
| Knowledge ( | 23 (17.2) | 13 (19.4) | 23 (13.9) | 72 (23.1)** | 13.51 (4) | .009 | |
| Known CRC ( | 83 (62.9) | 43 (63.2) | 105 (63.6) | 191 (62.0)** | 17.40 (4) | .002 | |
| Discussed FOBT ( | 65 (48.9)** | 39 (57.4) | 91 (55.2) | 120 (38.7)** | 57.59 (4) | <.001 | |
| Known a screener ( | 54 (40.6)** | 33 (48.5) | 63 (38.2)** | 93 (30.1)** | 63.00 (4) | <.001 | |
| Past other screening ( | 80 (60.2) | 39 (57.4) | 116 (70.3) | 174 (56.1)** | 14.42 (4) | .006 | |
| SR past FOBT (yes)b | 45 (33.6)** | 32 (47.1) | 83 (50.0) | 78 (25.0)** | 99.19 (4) | <.001 | |
Note. SD = standard deviation; F = F ratio; χ = chi square; p = probability; SES = socioeconomic status determined by SEIFA index of disadvantage; knowledge = response to knowledge item regarding the importance of repeated screening; Known CRC = known a person who has had CRC; Discussed FOBT = ever discussed FOBT screening; Known a screener = known a person who has screened for CRC; Other screening = ever participated in other (not CRC) screening tests. SR past FOBT = self-reported past FOBT use .variables were measured on increasing, continuous scales;comparative category is ‘no’;comparative category is ‘correct’ *p < .05, ** p < .01.
Multivariate predictors of non-adherence relative to consistent re-participation
| | | | | | | 1.01 | .620 | (0.98-1.03) | |||||
| | | | | | | | | | 0.97 | .231 | (0.91-1.02) | ||
| | | | | | | ||||||||
| | | | | | | | | | |||||
| | | | | | | | | | 1.01 | .452 | (0.99-1.04) | ||
| | | | | | | | | | 0.97 | .281 | (0.93-1.02) | ||
| | | | | | | | | | 0.88 | .173 | (0.73-1.06) | ||
| 1.02 | .917 | (0.71-1.47) | | | | | | | 0.97 | .806 | (0.77-1.23) | ||
| 0.86 | .390 | (0.60-1.22) | | | | ||||||||
| | | | | | | | | | |||||
| | | | | | | | | | 1.07 | .573 | (0.85-1.33) | ||
| | | | | | | | | | 0.88 | .168 | (0.73-1.06) | ||
| | | | | | | | |||||||
| 0.98 | .157 | (0.94-1.01) | |||||||||||
| | 1.38 | .116 | (0.93-2.05) | 1.05 | .869 | (0.60-1.82) | 1.21 | .302 | (0.84-1.75) | 1.25 | .064 | (0.99-1.57) | |
| | 0.77 | .133 | (0.54-1.09) | | | | | | | 0.82 | .068 | (0.67-1.02) | |
| | 1.43 | .076 | (0.96-2.13) | | | | | | | | | | |
| | | | | | | | | | | ||||
| | 0.75 | .501 | (0.33-1.73) | | | | | | | | | | |
| | | | | | | | | | | ||||
| | | | | | | | | | | 0.99 | .926 | (0.78-1.25) | |
| | | | | | | | | | | 0.87 | .312 | (0.66-1.14) | |
| | | | | | | | | | | ||||
| 0.76 | .098 | (0.55-1.05) | |||||||||||
Note. RR = risk ratio; p = probability; significance level is p<.05, significant values in bold; 95% CI = confidence interval. Social cognitive variables, GP visits and age were measured on increasing, continuous scales.
knowledge = response to knowledge item regarding the importance of repeated screening; Known CRC = known a person who has had CRC; Discussed FOBT = ever discussed FOBT screening; Known a screener = known a person who has screened for CRC; Other screening = ever participated in other (not CRC) screening tests; SR past FOBT = self-reported past FOBT use Cases with missing data were removed list wise, group totals reported in the table report the number of participants included in each analysis. Reference category is ‘no’ reference category is ‘correct’ reference category is ‘hospital and ancillary combined cover’; Reference category is ‘female’; Reference category is the fifth quintile of disadvantage (least disadvantage).
Multivariate predictors of non-adherence relative to consistent re-participation including a measure of prior satisfaction with FOBT
| 1.07 | .112 | (0.98-1.17) | | | | | | | 1.00 | .873 | (0.93-1.06) | ||
| | | | | | | | | | 1.01 | .936 | (0.89-1.14) | ||
| 1.00 | .965 | (0.94-1.17) | | | | | | | 1.00 | .847 | (0.96-1.05) | ||
| | | | | | | | | | 0.94 | .333 | (0.82-1.07) | ||
| | | | | | | | | | 1.02 | .455 | (0.97-1.08) | ||
| | | | | | | | | | 0.94 | .186 | (0.86-1.03) | ||
| | 0.99 | .960 | (0.66-1.48) | ||||||||||
| | | | | | | | | | 0.80 | .348 | (0.51-1.27) | ||
| 0.84 | .642 | (0.40-1.75) | | | | | | | 0.82 | .465 | (0.50-1.37) | ||
| 1.20 | .582 | (0.62-2.31) | | | | 0.76 | .183 | (0.51-1.14) | 0.74 | .153 | (0.49-1.11) | ||
| | | | | | | | | | |||||
| | | | | | | | | | 1.27 | .458 | (0.67-2.40) | ||
| | | | | | | | | | 0.97 | .891 | (0.63-1.50) | ||
| 0.99 | .654 | (0.93-1.05) | 0.96 | .218 | (0.89-1.03) | 0.97 | .209 | (0.93-1.02) | |||||
| 1.92 | .067 | (0.95-3.84) | 1.49 | .256 | (0.75-3.00) | 1.41 | .198 | (0.84-2.39) | .054 | ||||
| 0.95 | .896 | (0.45-1.95) | | | | | | | 0.98 | .918 | (0.61-1.57) | ||
| | | | | | | | | | |||||
| | | | | | | | | | |||||
| | | | | | | | | | 0.66 | .155 | (0.37-1.17) | ||
| | | | | | | | | | |||||
Note. RR= risk ratio; p= probability, 95% CI= confidence interval.Social cognitive variables, satisfaction, GP visits and age were measured on increasing, continuous scales. Health insurance was not included as a predictor in secondary analyses as cell sizes were <5 for drop out participants with only ancillary and only hospital cover.
knowledge= response to knowledge item regarding the importance of repeated screening; Known CRC= known a person who has had CRC; Discussed FOBT= ever discussed FOBT screening; Known a screener= known a person who has screened for CRC; Other screening= ever participated in other (not CRC) screening tests. a Cases with missing data were removed list wise, group totals reported in the table report the number of participants included in each analysis. b Reference category is ‘no’ c reference category is ‘correct’; d Reference category is ‘female’; e Reference category is the fifth quintile of disadvantage (least disadvantage).